Tenaya Therapeutics, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash & Equivalents | $100.5M | $4.3M | $45.7M | $95.3M | $38.1M | $128.5M |
| Accounts Receivable | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — |
| Total Current Assets | $105.6M | $67.4M | $111.6M | $193.8M | $255.4M | $130.0M |
| Property, Plant & Equipment | $27.7M | $35.9M | $43.3M | $51.0M | $43.0M | $17.2M |
| Goodwill | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — |
| Total Assets | $146.9M | $119.9M | $170.5M | $278.9M | $314.2M | $148.2M |
| Liabilities | ||||||
| Accounts Payable | $3.6M | $5.2M | $5.6M | $9.6M | $10.7M | $1.0M |
| Total Current Liabilities | $15.4M | $16.0M | $22.7M | $24.2M | $21.8M | $5.0M |
| Long-Term Debt | — | — | — | — | — | — |
| Total Liabilities | $23.7M | $27.1M | $31.1M | $35.6M | $35.7M | $8.7M |
| Stockholders' Equity | ||||||
| Retained Earnings | $-605.0M | $-514.4M | $-403.3M | $-279.2M | $-155.5M | $-82.8M |
| Total Stockholders' Equity | $123.3M | $92.9M | $139.4M | $243.4M | $278.5M | $-81.3M |